BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 4, 2008
View Archived Issues
Proof-of-concept study supports development of NBI-34041 for anxiety
Read More
Postmarketing study finds no increase in nonsuicide death with ziprasidone compared to olanzapine
Read More
ASF-1096 investigated in discoid and subacute lupus erythematosus
Read More
Aripiprazole data in Asperger's disorder and major depressive disorder reported
Read More
Takeda patents use of resatorvid for coronary surgical procedure complications
Read More
Pfizer initiates Japanese phase II clinical study of PF-03187207 for glaucoma
Read More
NCI files protocol for phase I/II clinical trial of Oncolytics' cancer drug Reolysin
Read More
Lundbeck begins phase I clinical studies of Lu-AA-37096 and stops development of Lu-AA-44608
Read More
GenVec makes protocol changes to phase II/III PACT trial of TNFerade for pancreatic cancer
Read More
ImmunoGen licenses exclusive right to develop IMGN-388 using Centocor antibody
Read More
Addex and Merck & Co. to codevelop drug candidate for schizophrenia
Read More
FDA approves Shire's new dosages for ADHD treatment Vyvanse
Read More
Xanthus' oral fludarabine therapy for CLL receives orphan drug designation
Read More
Recent Thallion patent discloses novel antiinfective agents
Read More
Recent Bayer patents report novel antithrombotic agents
Read More
New phase I/II trial for ispinesib monotherapy in metastatic breast cancer begins
Read More
XenoPort begins several clinical trials, gives update on other pipeline products
Read More
Amic enters license agreement with Roche Diagnostics for test for cardiac marker NT-proBNP
Read More
Takeda submits NDA for alogliptin in the U.S.
Read More
Addex announces ADX-10059 phase IIa acute anxiety data
Read More
Anti-HIV drug apricitabine enters phase III
Read More
